These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22889615)

  • 1. Pharmaco-refractory chronic heart failure--the need for drug level tailored management.
    Hazuková R; Praus R; Cermáková E; Fűrmanová V; Vojáček J; Pleskot M
    Med Hypotheses; 2012 Nov; 79(5):560-3. PubMed ID: 22889615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction.
    Carneiro AV
    Rev Port Cardiol; 2008 Jun; 27(6):851-6. PubMed ID: 18751512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of chronic heart failure].
    Watzinger N; Fruhwald FM; Klein W
    Wien Med Wochenschr; 1998; 148(5):128-30, 132-3. PubMed ID: 9654699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure.
    Krum H; Abraham WT
    Lancet; 2009 Mar; 373(9667):941-55. PubMed ID: 19286093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic systolic heart failure. Optimized pharmacotherapy improves prognosis].
    Stiefelhagen P
    Med Monatsschr Pharm; 2012 Nov; 35(11):416-8. PubMed ID: 23213711
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of emerging pharmacotherapy in chronic heart failure.
    Szabó T; Felger D; von Haehling S; Lainscak M; Anker SD; Doehner W
    Expert Opin Pharmacother; 2009 Sep; 10(13):2055-74. PubMed ID: 19606938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
    Gallegos PJ; Maclaughlin EJ; Haase KK
    Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy (or polytherapy) in the treatment of heart failure.
    Cleland JG; Baksh A; Louis A
    Heart Fail Monit; 2000; 1(1):8-13. PubMed ID: 12634876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart re-synchronization with biventricular stimulation: new treatment for refractory heart failure].
    Daubert JC; Leclercq C; Mabo P
    Bull Acad Natl Med; 2002; 186(1):45-55; discussion 56-7. PubMed ID: 12146141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis of heart failure--value of drug therapy].
    Felix SB
    Z Kardiol; 1996; 85 Suppl 4():1-7. PubMed ID: 9027102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
    Bristow MR; Saxon LA; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; DeMets D; White BG; DeVries DW; Feldman AM;
    N Engl J Med; 2004 May; 350(21):2140-50. PubMed ID: 15152059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
    Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
    Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?
    Abate E; Sartor R; Ceconi C; Boffa GM
    J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):893-905. PubMed ID: 20414119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of heart failure. General practice references for individual treatment].
    Goss F
    MMW Fortschr Med; 2000 Jun; 142(22):30-4. PubMed ID: 10870380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.